AN2 Therapeutics Inc./$ANTX
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.
- Ticker
- $ANTX
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- -
- Headquarters
- Menlo Park, United States
- Website
- www.an2therapeutics.com
ANTX Metrics
BasicAdvanced
$149M
-
-$1.04
-0.99
-
Price and volume
Market cap
$149M
Beta
-0.99
52-week high
$7.19
52-week low
$1.00
Average daily volume
297K
Financial strength
Current ratio
14.322
Quick ratio
14.089
Profitability
Management effectiveness
Return on assets (TTM)
-30.80%
Return on equity (TTM)
-50.12%
Valuation
Price to book
1.89
Price to tangible book (TTM)
1.89
Price to free cash flow (TTM)
-4.496
Free cash flow yield (TTM)
-22.24%
Free cash flow per share (TTM)
-0.88
Growth
Earnings per share change (TTM)
-16.56%
3-year earnings per share growth (CAGR)
-28.07%
What the Analysts think about ANTX
Analyst ratings (Buy, Hold, Sell) for AN2 Therapeutics Inc. stock.
Analyst projections of the future price of AN2 Therapeutics Inc. stock.
ANTX Financial Performance
Revenues and expenses
ANTX Earnings Performance
Company profitability
Upcoming events
No upcoming events
ANTX News
AllArticlesVideos
AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(c)(4)
Business Wire2 weeks ago
AN2 Therapeutics Announces Extension of Funding for Tuberculosis Research Collaboration with GSK
Business Wire1 month ago
AN2 Therapeutics, Inc. Reports Inducement Grants under Listing Rule 5635(c)(4)
Business Wire2 months ago
Funds containing ANTX
Fund name | Fund size | $ANTX weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.00% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.00% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.